Healthcare/Medical Simulation Market by Product and Service (Patient Simulators, High Fidelity Simulators, Low Fidelity Simulators, Task Trainer, Surgical Simulators, Virtual tutor) By End User (Academic Institutes, Hospital) - Global Forecast to 2026
[305 Pages Report] The healthcare/medical simulation market is projected to reach USD 3.4 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 15.1% during the forecast period. growing use of advanced methods and approaches for providing medical education, limited access to patients during medical training, increasing demand for minimally invasive treatments, increasing focus on patient safety, and increasing demand for virtual training interaction due to the COVID-19 pandemic. Vendors are using organic growth strategies such as product launches and innovations, which has resulted into an increasing availability of advanced products globally.
On the other hand, the limited availability of funds and poorly designed medical simulators are expected to restrain the growth of this market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on Healthcare/Medical Simulation Market
Owing to growing spread of COVID-19 infection, the hospitals became highly burdened. The necessary human and financial resources were diverted towards care management of COVID-19 patients, as a result, the healthcare facilities focused away from on-site training and learning. The supply chains of the vendors offering medical simulation products and services were disrupted due to lockdowns imposed by many countries globally.
However, the need for providing optimum care to the COVID-19 patients and to maintain safety standards for healthcare workforce became high priority, which resulted into a rising demand for virtual trainings and medical simulation solutions specific to COVID-19 patient. In response, many vendors such as CAE Inc (Canada), 3D Systems (US), Intelligent Ultrasound Group Plc (UK), and Laerdal Medical (Norway) introduced COVID-19 simulated training modules such as COVID-19 Ultraound Lung Simulators, which received positive response from end-users.
Medical Simulation Market Dynamics
Driver: Limited access to patients during medical training
Medical simulators have gained a valued spot in medical education across the globe as these stimulators exhibit characteristics of a human. Owing to limited access to patient and to maintain patient safety during training, the use of simulation in professional training programs and traditional learning is gaining adoption. The simulation allows students to sharpen their clinical and critical thinking skills for high-risk events. Pre‐education with simulation significantly enhances student knowledge, confidence in performance, ability in nursing practice, and satisfaction with learning methods compared with pre‐education or simulation alone. The training and education model is evolving, as evidenced by military branches around the world. Therefore, in medicine, simulation is offering significant scope for the enhanced training of interdisciplinary medical teams.
Restraint: limited availability of funds
The establishment of simulated learning environments and simulation programs requires significant capital investments, mainly due to the cost of high-fidelity simulators and virtual environments. In most cases, medical simulation training facilities rely heavily on government and private funding. In the past few years, there has been a decline in funding from government and private institutes, mainly due to rapid changes in medical technology, declining reimbursement for clinical services, rising wages of healthcare professionals, and reductions in federal GME payments. This has resulted in the lower-than-expected growth of the medical simulation market in developed countries across North America and Europe. Furthermore, the availability of funds is limited in developing nations in the Asia Pacific and Latin America regions, which further restricts the future growth of this market to a certain extent.
Opportunity: shortage of healthcare personnel
The shortage of skilled healthcare workers is the prime factor contributing to an increasing number of preventable deaths across the globe. According to the June 2021 article published by the Association of American Medical Colleges (AAMC), the rapidly increasing demand for physicians in the US will outpace its supply and is projected to create a shortfall of 37,80-124,000 physicians by 2034. Additionally, due to the ongoing COVID pandemic, the global healthcare industry is facing a severe shortage of healthcare workers. Physicians and nurses are frontline forces but are at a high risk of contracting COIVD-19. Many nursing schools worldwide are using technology in innovative ways to enhance teaching and learning capabilities. For instance, webcasting lectures are provided to a large number of students on several campuses. Clinical simulation centers and agreements with local healthcare service providers are helping the nursing schools secure clinical and other opportunities for students. This has increased the adoption of medical simulation solutions among end users, thereby offering lucrative growth opportunities to the vendors operating in the healthcare/medical simulation market.
Challenge: Stringent regulatory framework
Patient simulators are highly expensive devices, priced anywhere between USD 50,000 and USD 400,000 in developed nations, depending upon the type, services, brand and features. This is a key deterrent to their adoption in countries where the availability of government funding is limited. In developing nations, the need to ensure the affordability of medical simulation is a major challenge for the manufacturers.
The medical simulation and anatomical models is expected to dominate the product and service segment in healthcare/medical simulation market
Based on the product and service, the medical simulation and anatomical models segment accounted for the largest share of the global healthcare/medical simulation market in 2020. The large share of this segment can be attributed to the growing need for high fidelity (degree of realism) products, rising demand for primary care services, an increase in demand for patient safety, limited access to live patients, and the growing demand for minimally invasive surgeries.
Academic institutes in end-user segment accounted for the largest share of the healthcare/medical simulation market, in 2020
The healthcare/medical simulation market, by end-user, is segmented into academic institutes, hospitals, military organizations, and other end users. The academic institutes segment accounted for the largest market share in 2020. Factors such as growing awareness regarding patient safety, increasing focus on minimizing medical errors, and the rising number of medical school enrollees are expected to drive the growth of the medical simulation market for academic institutes during the forecast period.
North America accounted for the largest share of the healthcare/medical simulation market in 2020
In 2020, North America accounted for the largest share of the healthcare/medical simulation market, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa. The large share of this market segment can be characterized by growing access to technologies, well-established distribution channels, the rising number of healthcare professionals demanding hands-on patient training, and the rise in demand for virtual and online training due to the current COVID-19 pandemic. The introduction of cutting-edge technologies in medical simulators and strategic partnerships and agreements is enhancing companies' product and service portfolios.
Key Market Players
The prominent players in this market are CAE Inc. (Canada), 3D Systems (US), Laerdal Medical (Norway), Gaumard Scientific Co. (US), Kyoto Kagaku (Japan), Surgical Science Sweden AB (Sweden), Limbs and Things (UK), Mentice AB (Sweden), Simulab Corp. (US), and Intelligent Ultrasound Group Plc (UK).
Scope of the report
|
Report Metric |
Details |
|
Market size available for years |
20192026 |
|
Base year considered |
2020 |
|
Forecast period |
20212026 |
|
Forecast units |
Million (USD Billion) |
|
Segments covered |
Product and Service, and End User |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and Middle East and Africa |
|
Companies covered |
CAE Inc. (Canada), Laerdal Medical (Norway), 3D Systems (US), Gaumard Scientific Co. (US), Limbs & Things (US), Surgical Science Sweden AG (Sweden), Kyoto Kagaku (Japan), Mentice AB (Sweden), Intelligent Ultrasound Group Plc (UK), Simulab Corp. (US), Simulaids (US), Operative Experience, Inc. (US), Cardionics Inc. (US) (subsidiary of 3B Scientific), VirtaMed AG (Switzerland), IngMar Medical (US), Altay Scientific (Italy), Medical-X (The Netherland), KaVo Dental GmbH (Germany), Simendo B.V. (The Netherlands), VRMagic Holding AG (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), and Inovus Medical (UK) |
The study categorizes the healthcare/medical simulation market based on product and service, end user, and regional and global level.
Global Healthcare/Medical Simulation Market, by Product and service
- Medical simulation anatomical models
- Patient Simulators
- High Fidelity Simulators
- Medium Fidelity Simulators
- Low Fidelity Simulators
- Task Trainer
- Interventional Surgical Simulators
- Laparoscopic Surgical Simulators
- Gynecology Simulators
- Cardiovascular Simulators
- Orthopedic Simulators
- Spine Surgical Simulators
- Other Interventional /Surgical Simulators
- Endovascular Simulators
- Ultrasound Simulators
- Dental Simulators
- Eye Simulators
- Patient Simulators
- Web-Based Simulation
- Medical Simulation Software
- Performance Recording Software
- Virtual Tutors
- Simulation Training Services
- Vendor Based Training
- Education Societies
- Custom Consulting Services
Global Healthcare/Medical Simulation Market, by End User
- Academic Institutes
- Hospitals
- Military Organizations
- Other End Users
Global Healthcare/Medical Simulation Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- Uk
- Italy
- Spain
- Rest Of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In August 2021, IngMar Medical announced the launch of RespiPro, its next-generation respiratory and ventilation training solution
- In July 2021, SYNBONE AG announced the launch of Skull Holder System for use in Trauma, nuero surgery education, and orthognathic surgery.
- In May 2021, CAE Inc. announced the launch of CAE Vimedix 3.2, a high-fidelity ultrasound simulator with enhanced 3D and 4D scanning capabilities.
- In May 2021, Intelligent Ultrasound Group Plc. announced the launch of ScanNav PNB in UK, after receiving CE mark approval.
Frequently Asked Questions (FAQ):
Which are the top industry players in the global healthcare/medical simulation market?
The top market players in the global healthcare/medical simulation market include CAE Inc. (Canada), Laerdal Medical (Norway), 3D Systems (US), Gaumard Scientific Co. (US), Limbs & Things (US), Surgical Science Sweden AG (Sweden), Kyoto Kagaku (Japan), Mentice AB (Sweden), Intelligent Ultrasound Group Plc (UK), Simulab Corp. (US), Simulaids (US), Operative Experience, Inc. (US), Cardionics Inc. (US) (subsidiary of 3B Scientific), VirtaMed AG (Switzerland).
Which product and services have been included in the healthcare/medical simulation market report?
This report contains the following healthcare/medical simulation product and services:
- Medical Simulation Anatomical Models
- Web-Based Simulation
- Medical Simulation Software
- Simulation Training Services
Which geographical region is dominating in the global healthcare/medical simulation market?
The global healthcare/medical simulation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is the largest regional market for healthcare/medical simulation product and service. The large share of the region can be attributed to the presence of well-established distribution channels, growing access to technologies, the rise in demand for virtual and online training due to the current COVID-19 pandemic, and the rising number of healthcare professionals demanding hands-on patient training
Which is the leading segment by product and services?
The medical simulation anatomical models segment accounted for the largest market share. The demand for medical simulation anatomical models such as patient simulators and surgical simulators is increasing owing to an increase in demand for patient safety, rising demand for primary care services and growing need for high fidelity (degree of realism) products. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 33)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 MEDICAL SIMULATION MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 37)
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 MEDICAL SIMULATION MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Insights from primary experts
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION: MEDICAL SIMULATION MARKET
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE ANALYSIS OF THE TOP 3 PUBLIC COMPANIES: SURGICAL SEALANTS AND ADHESIVES SEGMENT (2020)
FIGURE 7 BOTTOM-UP APPROACHSEGMENTAL EXTRAPOLATION
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE MEDICAL SIMULATION MARKET (2021-2026)
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MEDICAL SIMULATION MARKET
3 EXECUTIVE SUMMARY (Page No. - 49)
FIGURE 11 MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 MEDICAL SIMULATOR MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 MEDICAL SIMULATION MARKET: REGIONAL SNAPSHOT
4 PREMIUM INSIGHTS (Page No. - 53)
4.1 MEDICAL SIMULATION MARKET OVERVIEW
FIGURE 15 ADVANCEMENTS IN MEDICAL TECHNOLOGY IS A KEY FACTOR DRIVING THE MARKET GROWTH
4.2 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2019)
FIGURE 16 MEDICAL SIMULATION ANATOMICAL MODEL SEGMENT AND JAPAN ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 MEDICAL SIMULATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
4.4 REGIONAL MIX: MEDICAL SIMULATION MARKET
FIGURE 18 NORTH AMERICA TO DOMINATE THE MEDICAL SIMULATION MARKET DURING THE FORECAST PERIOD
4.5 MEDICAL SIMULATION MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
FIGURE 19 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 57)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 MEDICAL SIMULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Limited access to patients during medical training
5.2.1.2 Rising technological advancements in medical education
5.2.1.3 Growing demand for minimally invasive treatments
5.2.1.4 Increasing focus on patient safety
5.2.1.5 Growing preference for virtual interaction due to the COVID-19 pandemic
5.2.2 RESTRAINTS
5.2.2.1 Limited availability of funds
5.2.2.2 Poorly designed medical simulators
5.2.3 OPPORTUNITIES
5.2.3.1 Shortage of healthcare personnel
5.2.3.2 Growing awareness for simulation training in emerging economies
5.2.4 MARKET CHALLENGES
5.2.4.1 High cost of simulators
5.2.4.2 Operational challenges
5.3 PORTERS FIVE FORCES ANALYSIS
TABLE 3 PORTERS FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 COVID-19 IMPACT ON THE MEDICAL SIMULATION MARKET
5.5 PRICING ANALYSIS
TABLE 4 PRICE RANGE FOR MEDICAL SIMULATION SOLUTIONS
5.6 TECHNOLOGY ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 MEDICAL SIMULATION MARKET: ECOSYSTEM ANALYSIS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR MEDICAL SIMULATION
FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2011JUNE 2021)
5.8.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 22 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL SIMULATION PATENTS (JANUARY 2011 TO JUNE 2021)
FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR MEDICAL SIMULATION PATENTS (JANUARY 2011 TO JUNE 2021)
6 INDUSTRY INSIGHTS (Page No. - 70)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 USE OF VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR) IN MEDICAL SIMULATION
6.2.2 HIGH-FIDELITY TECHNOLOGICAL ADVANCEMENTS
6.2.3 MULTIMODAL APPROACH IN THE DEVELOPMENT OF SIMULATORS
6.2.4 UTILISATION OF AI AND ML SOFTWARE IN SURGICAL PROCEDURES
6.2.5 GROWING USE OF HCIT/EMR
6.3 REGULATORY ANALYSIS
6.3.1 MEDICAL SIMULATION PRODUCTS
6.3.1.1 North America
6.3.1.1.1 US
TABLE 5 US: FDA CLASSIFICATIONS OF MEDICAL DEVICES
6.3.1.1.2 Canada
6.3.1.2 Europe
6.3.1.3 Asia Pacific
6.3.1.3.1 Japan
TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY
6.3.1.3.2 China
TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION
6.3.1.3.3 India
6.3.2 INTEROPERABILITY STANDARDS
TABLE 8 KEY STANDARDS FOR INTEROPERABILITY IN THE DIGITAL HEALTH SPECTRUM
TABLE 9 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN THE DIGITAL HEALTH SPECTRUM
7 GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE (Page No. - 79)
7.1 INTRODUCTION
TABLE 10 MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 11 MEDICAL SIMULATION MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2 MEDICAL SIMULATION ANATOMICAL MODELS
TABLE 12 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 13 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.1 PATIENT SIMULATORS
TABLE 14 PATIENT SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 15 PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 16 PATIENT SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.1.1 High-fidelity Simulators
7.2.1.1.1 The growing adoption of high-fidelity simulators in the educational training of healthcare professionals supports the market growth
TABLE 17 HIGH-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 18 HIGH-FIDELITY PATIENT SIMULATOR MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.1.2 Medium-fidelity simulators
7.2.1.2.1 Medium-fidelity simulation is largely opted for over high-fidelity owing to its cost benefits
TABLE 19 MEDIUM-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 20 MEDIUM-FIDELITY PATIENT SIMULATOR MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.1.3 Low-fidelity simulators
7.2.1.3.1 Growing adoption of simulation training, budgetary constraints, and ease of use are the factors responsible for the growth of this segment
TABLE 21 LOW-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 22 LOW-FIDELITY PATIENT SIMULATOR MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.2 TASK TRAINERS
7.2.2.1 The inability of task trainers to imitate the emotional attributes of patients is expected to restrain the growth of this segment
TABLE 23 TASK TRAINERS OFFERED BY KEY MARKET PLAYERS
TABLE 24 TASK TRAINERS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.3 INTERVENTIONAL/SURGICAL SIMULATORS
TABLE 25 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 26 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
7.2.3.1 Laparoscopic surgical simulators
7.2.3.1.1 Increasing preference for minimally invasive surgeries to drive the growth of this segment
TABLE 27 LAPAROSCOPIC SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 28 LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.3.2 Gynecology simulators
7.2.3.2.1 Increasing incidence of diseases such as fibroids and polyps in women has propelled the growth of this segment
TABLE 29 GYNECOLOGY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 30 GYNECOLOGY SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.3.3 Cardiovascular simulators
7.2.3.3.1 Increasing prevalence of obesity and diabetes to boost the demand for cardiovascular simulators
TABLE 31 CARDIOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 32 CARDIOVASCULAR SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.3.4 Orthopedic surgical simulators
7.2.3.4.1 Working through small portals with fragile instruments and being heavily time-consuming pose to be major challenges to the growth of this segment
TABLE 33 ORTHOPEDIC SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 34 ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.3.5 Spine surgical simulators
7.2.3.5.1 Increasing spinal injuries to boost the growth of this segment
TABLE 35 SPINE SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 36 SPINE SURGICAL SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.3.6 other surgical simulators
TABLE 37 OTHER SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 38 OTHER SURGICAL SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.4 ENDOVASCULAR SIMULATORS
7.2.4.1 Endovascular simulators help in reducing mortality rates and offer shorter recovery periods for patients as compared to vascular procedures
TABLE 39 ENDOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 40 ENDOVASCULAR SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.5 ULTRASOUND SIMULATORS
7.2.5.1 Poor quality images resulting from low dynamics, spatial resolution, and signal to noise ratio restrict the growth of this segment
TABLE 41 ULTRASOUND SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 42 ULTRASOUND SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.6 DENTAL SIMULATORS
7.2.6.1 The expanding dental tourism industry is driving the growing demand for dental simulators
TABLE 43 DENTAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 44 DENTAL SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.7 EYE SIMULATORS
7.2.7.1 The increasing incidence of eye disorders worldwide drive the growth of this segment
TABLE 45 EYE SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 46 EYE SIMULATORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.2.8 WEB-BASED SIMULATION
7.2.8.1 Rising technological advancements are driving the adoption of web-based simulation in developing countries
TABLE 47 WEB-BASED SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 48 WEB-BASED SIMULATION MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.3 MEDICAL SIMULATION SOFTWARE
TABLE 49 MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 50 MEDICAL SIMULATION SOFTWARE MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.3.1 PERFORMANCE RECORDING SOFTWARE
7.3.1.1 Compromised system integration and time constraints due to manual processes to restrain the growth of this segment
TABLE 51 PERFORMANCE RECORDING SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 52 PERFORMANCE RECORDING SOFTWARE MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.3.2 VIRTUAL TUTORS
7.3.2.1 Virtual reality helps reduce human errors in the medical sector
TABLE 53 VIRTUAL TUTORS OFFERED BY KEY MARKET PLAYERS
TABLE 54 VIRTUAL TUTORS MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.4 SIMULATION TRAINING SERVICES
TABLE 55 MEDICAL SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.4.1 VENDOR-BASED TRAINING
7.4.1.1 High focus on patient safety for real-time clinical practices to propel the growth of the segment
TABLE 56 VENDOR-BASED TRAINING SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 57 VENDOR-BASED TRAINING SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.4.2 EDUCATIONAL SOCIETIES
7.4.2.1 The growing need for proper training and authenticity of knowledge drives the growth of this segment
TABLE 58 EDUCATIONAL SOCIETIES SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 59 EDUCATIONAL SOCIETIES MARKET, BY COUNTRY, 20192026 (USD MILLION)
7.4.3 CUSTOM CONSULTING SERVICES
7.4.3.1 The growing need to limit errors associated with traditional medical training systems to drive the growth of this segment
TABLE 60 CUSTOM CONSULTING SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 61 CUSTOM CONSULTING SERVICES MARKET, BY COUNTRY, 20192026 (USD MILLION)
8 GLOBAL MEDICAL SIMULATION MARKET, BY END USER (Page No. - 125)
8.1 INTRODUCTION
TABLE 62 MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
8.2 ACADEMIC INSTITUTES
8.2.1 THE GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS IS EXPECTED TO INCREASE THE USE OF MEDICAL SIMULATORS IN ACADEMIC INSTITUTIONS
TABLE 63 MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 20192026 (USD MILLION)
8.3 HOSPITALS
8.3.1 THE SURGING NUMBER OF COVID-19 PATIENTS AND THE RISING FOCUS ON MINIMIZING MEDICAL ERRORS ARE KEY FACTORS DRIVING THE GROWTH OF THIS SEGMENT
TABLE 64 MEDICAL SIMULATION MARKET FOR HOSPITALS, BY COUNTRY, 20192026 (USD MILLION)
8.4 MILITARY ORGANIZATIONS
8.4.1 INCREASING USE OF SIMULATORS TO EXPLORE NEW METHODS OF MEDICAL CARE DURING WARFARE CONDITIONS IS EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 65 MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY COUNTRY, 20192026 (USD MILLION)
8.5 OTHER END USERS
TABLE 66 MEDICAL SIMULATION MARKET FOR OTHER END USERS, BY COUNTRY, 20192026 (USD MILLION)
9 GLOBAL MEDICAL SIMULATION MARKET, BY REGION (Page No. - 132)
9.1 INTRODUCTION
FIGURE 24 MEDICAL SIMULATION MARKET: GEOGRAPHIC SNAPSHOT
TABLE 67 MEDICAL SIMULATION MARKET, BY REGION, 20192026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: MEDICAL SIMULATION MARKET SNAPSHOT (2020)
TABLE 68 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 69 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 70 NORTH AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 71 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 72 NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 73 NORTH AMERICA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 74 NORTH AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 75 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.2.1 US
9.2.1.1 The increasing demand for virtual tutors due to the COVID-19 pandemic and high healthcare spending to boost the market growth in the US
TABLE 76 US: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 77 US: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 78 US: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 79 US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 80 US: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 81 US: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 82 US: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing funding and surgical capabilities to drive the market growth in Canada
TABLE 83 CANADA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 84 CANADA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 85 CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 86 CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 87 CANADA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 88 CANADA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 89 CANADA: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.3 EUROPE
FIGURE 26 EUROPE: MEDICAL SIMULATION MARKET SNAPSHOT (2020)
TABLE 90 EUROPE: MEDICAL SIMULATION MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 91 EUROPE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 92 EUROPE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 93 EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 94 EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 95 EUROPE: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 96 EUROPE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 97 EUROPE: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 High healthcare spending to be the key driver for market growth in Germany
TABLE 98 GERMANY: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 99 GERMANY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 100 GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 101 GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 102 GERMANY: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 103 GERMANY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 104 GERMANY: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Growing focus towards the use of innovative methods of medical training to drive the market growth for simulators in France
TABLE 105 FRANCE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 106 FRANCE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 107 FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 108 FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 109 FRANCE: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 110 FRANCE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 111 FRANCE: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing healthcare expenditure and the rising number of healthcare simulation centers & hospitals in the UK to support the market growth
TABLE 112 UK: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION) (USD MILLION)
TABLE 113 UK: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 114 UK: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 115 UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 116 UK: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 117 UK: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 118 UK: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 The growing burden of chronic conditions and the shortage of trained healthcare professions drive the demand for medical simulators in Italy
TABLE 119 ITALY: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 120 ITALY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 121 ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 122 ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 123 ITALY: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 124 ITALY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 125 ITALY: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing surgical procedures to boost the demand for simulators in Spain
TABLE 126 SPAIN: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 127 SPAIN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 128 SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 129 SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 130 SPAIN: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 131 SPAIN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 132 SPAIN: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.3.6 REST OF EUROPE (ROE)
TABLE 133 ROE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 134 ROE: MANNEQUIN-BASED SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 135 ROE: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 136 ROE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 137 ROE: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 138 ROE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 139 ROE: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: MEDICAL SIMULATION MARKET SNAPSHOT (2020)
TABLE 140 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 141 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 142 ASIA PACIFIC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 143 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 144 ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 145 ASIA PACIFIC: MEDICAL SIMULATION SOFTWARE MARKET, BY PRODUCT, 20192026 (USD MILLION)
TABLE 146 ASIA PACIFIC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 147 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Increasing demand for virtual tutors and technologically advanced simulators to drive the market growth in Japan
TABLE 148 JAPAN: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 149 JAPAN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 150 JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 151 JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 152 JAPAN: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 153 JAPAN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 154 JAPAN: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Growing demand for trained medical professionals to drive the market growth for medical simulators in China
TABLE 155 CHINA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 156 CHINA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 157 CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 158 CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 159 CHINA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 160 CHINA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 161 CHINA: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing awareness regarding patient safety due to healthcare negligence is a key factor supporting the market growth in India
TABLE 162 INDIA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 163 INDIA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 164 INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 165 INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 166 INDIA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 167 INDIA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 168 INDIA: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 169 ROAPAC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 170 ROAPAC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 171 ROAPAC: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 172 ROAPAC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 173 ROAPAC: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 174 ROAPAC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 175 ROAPAC: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 176 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 177 LATIN AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, 20192026 (USD MILLION)
TABLE 178 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 179 LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 180 LATIN AMERICA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 181 LATIN AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, 20192026 (USD MILLION)
TABLE 182 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 High incidence of chronic diseases to drive the demand for medical simulators in Brazil
TABLE 183 BRAZIL: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 184 BRAZIL: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 185 BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 186 BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 187 BRAZIL: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 188 BRAZIL: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 189 BRAZIL: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Disruptive technologies and private-public partnerships to boost the healthcare sector for medical simulation in Mexico
TABLE 190 MEXICO: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 191 MEXICO: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 192 MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 193 MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 194 MEXICO: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 195 MEXICO: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 196 MEXICO: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 197 ROLA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 198 ROLA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 199 ROLA: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 200 ROLA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 201 ROLA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 202 ROLA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 203 ROLA: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
TABLE 204 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 20192026 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, 20192026 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 210 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY END USER, 20192026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 199)
10.1 OVERVIEW
FIGURE 28 KEY PLAYER STRATEGIES
10.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 29 REVENUE ANALYSIS OF TOP PLAYERS IN THE MEDICAL SIMULATION MARKET
10.3 MARKET SHARE ANALYSIS
FIGURE 30 MEDICAL SIMULATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
FIGURE 31 SURGICAL SIMULATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 211 INSIGHTS ON THE TOP AND OTHER PLAYERS IN THE SURGICAL SIMULATORS MARKET
10.4 COMPETITIVE LEADERSHIP MAPPING
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 32 MEDICAL SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
10.5.1 PROGRESSIVE COMPANIES
10.5.2 DYNAMIC COMPANIES
10.5.3 STARTING BLOCKS
10.5.4 RESPONSIVE COMPANIES
FIGURE 33 MEDICAL SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
10.6 COMPETITIVE SCENARIO
10.6.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 212 PRODUCT LAUNCHES & APPROVALS, 20182021
10.6.2 DEALS
TABLE 213 DEALS (20182021)
10.6.3 OTHER STRATEGIES
TABLE 214 OTHERS (2018-2021)
10.7 COMPETITIVE BENCHMARKING
FIGURE 34 FOOTPRINTS OF THE COMPANY IN THE MEDICAL SIMULATION MARKET
TABLE 215 COMPANY PRODUCT AND SERVICE OFFERING FOOTPRINT (25 COMPANIES)
TABLE 216 COMPANY REGION FOOTPRINT (25 COMPANIES)
11 COMPANY PROFILES (Page No. - 217)
11.1 KEY PLAYERS
(Business Overview, Products/ Services Offered, Recent Developments, and MnM View)*
11.1.1 CAE INC.
FIGURE 35 CAE: COMPANY SNAPSHOT (2020)
11.1.2 3D SYSTEMS
FIGURE 36 3D SYSTEMS: COMPANY SNAPSHOT (2020)
11.1.3 LAERDAL MEDICAL
11.1.4 GAUMARD SCIENTIFIC CO.
11.1.5 KYOTO KAGAKU
11.1.6 LIMBS & THINGS
11.1.7 MENTICE AB
FIGURE 37 MENTICE AB: COMPANY SNAPSHOT (2020)
11.1.8 SIMULAB CORP.
11.1.9 SIMULAIDS
11.1.10 INTELLIGENT ULTRASOUND GROUP PLC
FIGURE 38 INTELLIGENT ULTRASOUND GROUP PLC: COMPANY SNAPSHOT (2020)
11.1.11 OPERATIVE EXPERIENCE INC.
11.1.12 SURGICAL SCIENCE SWEDEN AB
FIGURE 39 SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT (2020)
11.1.13 CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC)
11.1.14 VIRTAMED AG
11.1.15 SYNBONE AG
11.1.16 INGMAR MEDICAL
11.1.17 MEDICAL-X
11.1.18 KAVO DENTAL GMBH
11.1.19 ALTAY SCIENTIFIC
11.1.20 SIMENDO B.V.
* Business Overview, Products/ Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 VRMAGIC HOLDING AG.
11.2.2 SYMGERY
11.2.3 HRV SIMULATION
11.2.4 SYNAPTIVE MEDICAL
11.2.5 INOVUS MEDICAL
12 APPENDIX (Page No. - 295)
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global healthcare/medical simulation market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the healthcare/medical simulation market. The primary sources from the demand side include medical practitioners and hospital managers.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product and service, end user, and region).
Data Triangulation
After arriving at the market size, the total healthcare/medical simulation market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, segment, and forecast the healthcare/medical simulation market by product and service, end user, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall healthcare/medical simulation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the healthcare/medical simulation market in five main regions (along with their respective key countries), namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile the key players in the healthcare/medical simulation market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions; new product launches; expansions; collaborations, agreements, and partnerships; and R&D activities of the leading players in the healthcare/medical simulation market
- To benchmark players within the healthcare/medical simulation market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product and service strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your companys specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific biosurgery market into Australia, New Zealand and others
- Further breakdown of the Rest of Europe biosurgery market into The Netherlands, Sweden, Norway and others
Get in-depth analysis of the COVID-19 impact on the Healthcare/Medical Simulation Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Healthcare/Medical Simulation Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Healthcare/Medical Simulation Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Healthcare/Medical Simulation Market